Sarcoma trials in Belgium
13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
- Where
- Edegem, Hasselt, Liège, Mons
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07541170 · EU 2025-524263-21-01 - Phase 1Taking peopleAnti-GD2 ADC M3554 in Advanced Solid Tumors
- Where
- Leuven
- Age
- 18 years and over
- People
- 65 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT06641908 · EU 2024-513687-26-00 - Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Gent
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - Phase 3Taking peopleInternational Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- Where
- Brussels, Edegem, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- Up to 64 years
- People
- 1,351 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501180-40-00 · EU 2022-501180-40-00 - Phase 1/2Taking peopleFirst-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
- Where
- Leuven
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- Adcendo ApS
See details and how to joinNCT06797999 · EU 2024-516900-41-00 - Phase 1Taking peopleFirst-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
- Where
- Leuven
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06644755 - No phaseTaking peopleProspective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
- Where
- Leuven
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Australia and New Zealand Sarcoma Association
See details and how to joinNCT07377747 - Phase 1/2Taking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Leuven
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseNot yet taking people in BelgiumBone Arches: Performance of Pseudo-scanner Sequences in Segmenting the Extent of the Tumour and in Planning Surgical Resection Using the CT Scan as a Reference
- Where
- Brussels
- Age
- 18 years and over
- People
- 122
- Run by
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
See details and how to joinNCT06988007 - No phaseTaking peopleAssessment of the Functional Outcome and Quality of Life in Sarcoma Patients
- Where
- Leuven
- Age
- 18 years to 95 years
- People
- 60
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT05051059 - Phase 2/3Taking peoplerEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma
- Where
- Sint-Lambrechts-Woluwe
- People
- 436 worldwide
- Run by
- The University Of Birmingham
See details and how to join2024-516078-31-00 · EU 2024-516078-31-00 - No phaseTaking peopleStereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
- Where
- Anderlecht, Ghent, Wilrijk
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767 - Phase 1/2Taking peopleFaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
- Where
- Brussels, Edegem, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- People
- 1,672 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT04625907 · EU 2024-510579-40-00